SAVS makes travel scholarship applications call for 2024 meeting
The Southern Association for Vascular Surgery (SAVS) has put out a call for applications from medical students and general surgery residents for 20 travel...
VRIC 2024 set for May 15
The 2024 Society for for Vascular Surgery (SVS) Vascular Research Initiatives Conference (VRIC), which concentrates on basic and translational vascular science, will take place...
Popliteal artery lesions: Two-year results from European DCB catheter registry announced
“We face a scarcity of data evaluating endovascular therapy for isolated popliteal artery lesions, known as a difficult vessel bed to treat as we...
When women are PIs: A story foretold on the vascular frontlines
“Multifactorial” issues persist in gender representation in vascular leadership and trial enrollment, leading women vascular surgeons tell Vascular Specialist.
"We would have fewer untoward side...
Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel...
Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair.
A...
SVS launches national smoking cessation initiative
The Society for Vascular Surgery’s Patient Safety Organization (SVS PSO) has formally launched a national smoking cessation initiative. It includes tools and resources to help physicians,...
FDA approves LimFlow system for ‘no-option’ CLTI patients
The Food and Drug Administration (FDA) today announced approval of LimFlow therapy—a novel and minimally invasive procedure designed to bypass blockages in arteries of...
MVSS 2023: Aulivola takes over Midwestern Vascular reins
Bernadette Aulivola, MD, the division director of vascular surgery and endovascular therapy at Loyola University in Maywood, Illinois, took over as president of the...
EVS 2023: Ozsvath assumes Eastern Vascular presidency
Kathleen Ozsvath, MD, a vascular surgeon at St. Peters Health Partners in Albany, New York, took over as president of the Eastern Vascular Society...
FDA clears AAA-SHAPE trial for IDE approval
Shape Memory Medical recently announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin a...
Multi-society guidelines on varicose vein management published
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part...
Vascular Nurses Week shines spotlight on vital role in patient care and innovation
In a world in which both medical breakthroughs and technological advancements seem to dominate the healthcare landscape, it’s easy to overlook the unsung heroes...
SVS urges members to take part in compensation survey—and bolster results
Organizers behind an SVS-commissioned financial compensation survey are calling on more members to fill out the short list of questions so that they can...
CMS: Proposed reduced conversion factor would cut vascular surgeon reimbursements
The Centers for Medicare & Medicaid Services (CMS) in mid-July released two payment-related proposed rules—the highly-anticipated calendar year (CY) 2024 Medicare Physician Fee Schedule...
Submit ideas for VAM 2024 educational sessions
Organizers of VAM 2024 want members to consider what the modern-day vascular surgeon needs to know for optimal patient care and professional success. What’s...
SVS members rally to respond to CMS carotid stenting coverage proposal
Nearly one-third of the public comments submitted to the Centers for Medicare & Medicaid Services (CMS) on a controversial proposed coverage decision affecting carotid...
Empowering vascular surgery to promote five pivotal healthcare bills before Congress
Welcome back to Government Grand Rounds, a campaign aimed at expanding vascular surgeons’ understanding of—and comfort with—the SVS’ many advocacy tools. In the dynamic...
Coding and complex PAD: Register today for two SVS courses
Limited spots remain open for two popular SVS courses coming in October: the Complex Peripheral Vascular Interventions (CPVI) Skills Course on Oct. 1–2 and...
Step off Friday for SVS Vascular Health Step Challenge
The month of September begins Friday and with it, the SVS Foundation’s Vascular Health Step Challenge.
The initiative challenges participants to walk 60 miles—representing the...
First US patient enrolled in SOCRATES short neck AAA trial
The first U.S. patient has been treated as part of the SOCRATES trial (Short neck AAA randomized trial—ESAR and FEVAR), which compares the safety...
The price of a cup of coffee
In the wake of the coverage of inappropriate vascular interventions in the mainstream press, guest editorialist Adam Tanious, MD, tackles the thorny issue of...
Endovascular stablization system for infrarenal AAAs gains FDA Fast Track designation
Nectero Medical announced that the Food and Drug Administration (FDA) has granted Fast Track designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST)...
Venous stenting and the IVC: ‘Persistent problems’ in the setting of post-thrombotic syndrome
The question of “persistent problems” with venous stenting among post-thrombotic syndrome (PTS) patients emerged as a key talking point during the recent Deep Venous...
Congress considers incremental steps towards Medicare payment reform
There is no doubt that the Medicare payment system needs reform. At this moment, the SVS is aiming to inspire reform through all facets...
First patient treated in global strategic collaboration involving Cydar Maps technology
Cydar Medical has announced the successful treatment of the first patient in a strategic collaboration with Medtronic. The collaboration, which spans 40 sites across...
Clinical performance of Human Acellular Vessel amid war in Ukraine presented at military research...
Clinical outcomes of Humacyte's investigational Human Acellular Vessel (HAV) were presented at the Military Health System Research Symposium in Kissimmee, Florida (Aug. 14–17), following...
Child-bearing age ‘should not be a contraindication to venous stenting’
In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...
Study finds no correlation between IVC filter placement position and device complications
Researchers report that inferior vena cava (IVC) filter placement position relative to the level of the most inferior renal vein was not associated with...
Learn coding intricacies at October workshop on reimbursement
The SVS will host the SVS Coding and Reimbursement Workshop this fall, providing a comprehensive program designed to equip vascular surgeons and their support...
Your SVS: Executive Board sets course for year
Phase II of a national branding campaign for vascular surgery and three new task forces are just two of several initiatives the SVS’ Executive...
UCLA-SVS review course is this month
Time is running out to plan attendance at the annual course, A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery,...
Corner Stitch: Supplementing our formal learning as vascular trainees
As a vascular surgery trainee, there are multiple aspects of vascular surgery that I’ve had the opportunity to learn about. And to be honest,...
Breaking ground: A trial to improve the care of uncomplicated type B aortic dissection
Because high-quality evidence from large, prospective multicenter trials on the best treatment of uncomplicated type B aortic dissection (uTBAD) is scarce, SVS members Firas...
VQI Fellows in Training program marks one year
The Vascular Quality Initiative (VQI) Fellows in Training (FIT) program is a success, said leaders as they provided a one-year review.
FIT introduces residents and...
SVS members get ready for second annual vascular health awareness event
September's Vascular Health Step Challenge is fast-approaching, and SVS members are preparing to step up to meet it.
The challenge benefits the SVS Foundation,...
SVS responds to CMS proposed coverage expansion for carotid stenting
The Society for Vascular Surgery (SVS) and its affiliated Patient Safety Organization (PSO)/Vascular Quality Initiative (VQI) have submitted a formal response to the Centers...
WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study completes enrolment
Merit Medical has announced that it has completed enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective,...
SCVS president becomes chair of American Board of Surgery
The American Board of Surgery (ABS) has named Society for Clinical Vascular Surgery (SCVS) President M. Ashraf Mansour, MBBS, as its 2023–24 chair. He...
Light-activated drug-coated balloon granted FDA approval for clinical study
Alucent Biomedical has announced that the Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a U.S. clinical study of AlucentNVS,...
‘Vascular surgery should be a key member of pulmonary embolism response teams’
“PERT care is the coalition of the willing,” quipped Dennis Gable, MD, a vascular surgeon at Texas Vascular Associates in Plano, Texas. He was...
SVS urges members to make voices heard on CMS carotid stenting coverage expansion
The SVS has created a template to help members transmit comments to the Centers for Medicare & Medicaid Services (CMS) regarding proposed major adjustments...
‘FDA’s mission to bring safe and effective vascular surgery devices to market remains steadfast’
The Vascular and Endovascular Devices Team (VEDT) in the Food and Drug Administration (FDA) Office of Cardiovascular Devices appreciates the Vascular Specialist editorial board's...
The top 10 most popular Vascular Specialist stories of July 2023
In the previous month, Vascular Specialist delivered a range of leading commentary from the Society for Vascular Surgery (SVS) in response to the New...
Newest JVS peer-review title appoints editor-in-chief
The Journal of Vascular Surgery (JVS) has announced the appointment of Anahita Dua, MD, as the editor-in-chief of the Journal of Vascular Surgery-Vascular Insights...
Financial viability, appropriate use and patient safety in the operation of outpatient facilities
The number of office-based facilities has been increasing steadily over the past several years—and more vascular surgeons may be considering becoming involved in operating...
Comments sought on CMS proposed coverage expansion for carotid stenting
SVS members are encouraged to submit comments—due Aug. 10—to the Centers for Medicare & Medicaid Services (CMS) on its proposed national coverage determination on...
New study reports positive performance of AI-powered assessment of biomarkers for growth prediction of...
The characterization of aortic tissue by means of three key biomechanics-based biomarkers bundled into a compound Regional Areas of Weakness (RAW) Map showed “very...
Vascular surgery added as named specialty to influential national hospital rankings
U.S. News & World Report has renamed the specialty formerly known as “Cardiology & Heart Surgery” to include vascular surgery in its national rankings of...
Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel for vascular trauma...
Humacyte today announced completion of enrollment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA)...
SVS Foundation adds two surgeons to board of directors
The Society for Vascular Surgery (SVS) Foundation has announced the appointment of Bernadette Aulivola, MD, and Vikram Kashyap, MD, to its board of directors. Both...
The Golden Larva syndrome: Is it real?
Failure is part of the process that leads to success. Occasional failures may sting but we must recognize the adage that failure is a...
Nectero Medical receives FDA clearance of IND application to initiate Phase II/III clinical trial...
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted investigational new drug (IND) clearance for the company to initiate...
Endologix announces first patients treated with the Detour system
Endologix has shared in a press release that the first patients underwent percutaneous transmural arterial bypass (PTAB) using the Detour system since Food and Drug...
SVS coding workshop coming in October
The SVS’ 2023 Coding and Reimbursement Workshop will help participants learn about accurate coding and reimbursement for vascular surgery. The intensive two-day program will...
Crawford panel looks at opportunities to plug and extend vascular surgery workforce pipeline
This year’s E. Stanley Crawford Critical Issues Forum zeroed in on the pipeline of sources feeding the vascular surgery ranks. Incoming SVS President Joseph...
SVS responds to New York Times article on overuse of vascular interventions
In an official Society response, SVS President Joseph Mills, MD, tackles recent coverage in the mainstream media of inappropriateness in vascular care.
There have been...
The numbers are in: VAM 2023 adds up to another SVS classic
Landmark meeting (June 14-17) with nearly 1,400 vascular professionals moves the needle with program innovations, slew of new science and jam-packed agenda.
With more content...
Second edition of VSITE review text released
The second edition of a hit trainee-created textbook primarily aimed at those taking the Vascular Surgery In-Training Exam (VSITE) has hit the shelves.
The Vascular...
SVS seeks volunteers to write position paper
Society for Vascular Surgery (SVS) members have until July 31 to apply to serve on a new SVS writing group to develop a position...
Study finds similar rates of VTE in both flying and non-flying surgical patients
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...
Long-awaited FDA update finds data do not support excess mortality risk for paclitaxel-coated devices
In a letter to healthcare providers dated July 11, 2023, the Food and Drug Administration (FDA) communicates that the risk of mortality associated with...
VESAP5 expires July 14
The SVS’ fifth edition of the Vascular Education and Self- Assessment Program (VESAP5) expires at 9 a.m. CDT July 14 and with it, the...
Review urges development of protocols to reduce hypersensitivity reactions after cyanoacrylate varicose vein treatment
Despite being considered “generally safe,” cyanoacrylate can cause local reactions in up to 25% of patients, disproportionately affecting women, Asian race and thin patients...
The top 10 most popular Vascular Specialist stories of June 2023
Last month, Vascular Specialist garnered readers' attention with an array of commentary on the BEST-CLI and BASIL-2 trials; the medical editor's interview with vascular...
Surmodics receives FDA approval for the SurVeil drug-coated balloon
Surmodics has announced the receipt of Food and Drug Administration (FDA) approval for the SurVeil drug-coated balloon (DCB).
A company press release notes that the...
FDA approves study of ZFEN+ for treatment of aortic aneurysms
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Zenith fenestrated+...
SVS mourns death of Past President Kenneth Wayne Johnston
The Society for Vascular Surgery (SVS) mourns the death of Kenneth Wayne Johnston, an SVS member, former president and recipient in 2009 of the...
Risk of cancer-related VTE recurrence ‘significantly lower’ using NOACs compared with low molecular weight...
Delivering results and recommendations from a systematic review and meta-analysis of novel oral anticoagulants (NOACs) versus low molecular weight heparin (LMWH) in the prevention...
Vascular Verification Program registers first four hospitals in US—including UCSF
UC San Francisco Medical Center (UCSF) is among the first four hospitals in the U.S. to be verified as part of the American College of...
Assessing the needs of young vascular patients
In the past 18 months, a joint taskforce studying the needs of pediatric vascular patients has made great strides, conducting a needs assessment, identifying...
New analysis probes BEST-CLI trial against real-world setting data
A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
Bias and the silver bullet: Gender partiality seen within AI algorithms for AAA identification
Artificial intelligence (AI) has become a central focus within various spheres, from commerce to medicine—including applications in patient care. Sharon Kiang, MD, talks to...
Advocacy exists to serve: Surgeons, patients and our mission
One of the most gratifying aspects of working to advocate for surgeons is that, at its heart, this is completely transparent and is done...
Physical pain a risk factor for vascular surgery trainee burnout, survey reveals
A recent survey has indicated that physical pain is “prevalent” among vascular surgery trainees and represents a risk factor for burnout. Eric Pillado, MD,...
VAM attendees chime in on BEST-CLI and BASIL-2
VS@VAM journalist Will Date and videographer Jean-Philippe Bensoussan caught some VAM 2023 foot traffic outside the BEST-CLI and BASIL-2: Debate, Analysis and Implementation session...
‘Vigilant’ surveillance and low threshold for further interventions ‘crucial’ following rescue of prior EVAR...
The findings of a recent study on reinterventions and sac dynamics after fenestrated endovascular aneurysm repair (FEVAR) with a physician-modified endograft (PMEG) for index...
Two-year DETOUR2 study results presented at VAM 2023
Endologix has announced the 24-month results of the DETOUR2 study, presented at VAM 2023, the annual meeting of the Society for Vascular Surgery (SVS),...
SVS announces new vice president and treasurer following 2023 election
The Society for Vascular Surgery (SVS) has announced the latest additions to its officer roll following the 2023 elections for Society vice president and...
Nephrologist insights for vascular surgeons at hemodialysis access session
Friday afternoon in Potomac D will see VAM play host to a series of presentations on access for hemodialysis that will offer education on...
Improved fistulas and cost-effectiveness promised in plenary 5 abstract presentation
Friday morning’s Plenary Session 5 (8:00–9:30 a.m.) is set to feature new data on an external support device that may deliver more functional arteriovenous...
Future research needed to ‘optimize’ use of imaging technologies during aortic procedures
Imaging technologies in the aortic space will be a key feature of Saturday’s Plenary Session 8 (11:15 a.m. to 12:30 p.m.) in Potomac A/B,...
Study shows performance on the vascular qualifying examination does not predict performance on the...
A national cohort study of vascular trainees taking the Vascular Qualifying Examination (VQE) and the Vascular Certifying Examination (VCE) found performance during the former...
Novel drug candidate for slowing AAA growth demonstrates safety in humans
The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data...
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in the name of...
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they...
Generational divide: Do baby boomers and millennials see eye-to-eye on vascular surgery training needs?
Older-generation vascular surgeons are keen to hone their endovascular skills, while the younger generation are looking to develop their capacity to treat aortic pathologies—but...
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled...
Presidential address: ‘The annual meeting is only part of our story’
Friday morning will see Michael C. Dalsing, MD, MBA, deliver what is an annual hallmark of the VAM program—the SVS Presidential Address.
From 11:00 a.m.–12:15...
Carotid revascularization capable of improving mood in depressed patients with carotid atherosclerosis
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements...
The global burden of CLTI: ESVS President points toward need for new global vascular...
Early-bird VAM 2023 attendees yesterday gained broad insight into the issues facing vascular surgeons around the world, with the tone set from the opening...
Cross-specialty approach to embolization ‘provides the best care for patients’
Shang Loh, MD, is chief of vascular surgery and endovascular therapy at Penn Presbyterian Medical Center in Philadelphia and professor of clinical surgery at...
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD,...
VAM 2023: Vascular Quality Initiative launches national smoking cessation drive
The SVS Patient Safety Organization (SVS PSO) has launched a national smoking cessation initiative.
SVS PSO Associate Medical Director Gary Lemmon, MD, and SVS PSO...
Risk assessment models “no better than coin toss” for predicting bleeding in patients considered...
A study of two risk assessment models (RAMs) for predicting the bleeding risk in patients considered for pharmacologic prophylaxis to prevent venous thromboembolism (VTE)...
Opening ceremony heralds ‘power’ of VAM attendance
SVS President Michael Dalsing, MD, officially opened the 2023 Vascular Annual Meeting (VAM) yesterday morning, telling attendees at the early morning Opening Ceremony: “For...
VAM 2023: Vascular trauma session to highlight the current role of endovascular therapy
A focused session on vascular trauma yesterday took a deep dive into emerging issues and controversies in the field.
Moderated by Sherene Shalhub, MD, of...
Prediction model offers new option for forecasting AAA growth
A predictive model incorporating 3D shape features such as aneurysmal flow lumen and outer wall structure extracted from computed tomography (CT) imaging can improve...
VAM 2023: ‘What I wish I knew before retirement’ talk gives insight into adaptation...
Reflecting on the positives and negatives of retirement, Peter Gloviczki, MD, from the Mayo Clinic, previously in Rochester, Minnesota, now in Scottsdale, Arizona, and...
VAM 2023: Endovascular thermal septotomy for chronic post-dissection aortic aneurysm
Aidin Baghbani-Oskouei, MD, and Gustavo S. Oderich, MD, from the University of Texas Health Science Center at Houston, Texas, detail the endovascular thermal septotomy...
CEA associated with less reintervention than stenting in first six months-study
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA...
Special invited research presentations offered at VAM
VAM traditionally includes presentations from specially invited translational researchers that are performing cutting-edge work focused on vascular disease. All are held during plenary sessions.
“These...
Study weighs up total transfemoral and upper extremity approaches for F/BEVAR
In a prospective, non-randomized study, researchers found that a total transfemoral approach was associated with lower rates of cerebrovascular events and improved outcomes compared...
Onco-vascular session set to offer ‘clinical pearls’ in ‘new’ area of vascular surgery
Randall DeMartino, MD, is Division Chair of Vascular and Endovascular Surgery at the Mayo Clinic in Rochester, Minnesota, and a co-moderator of a session...
Analyses offer a deeper dive into BEST-CLI trial data
As the vascular community continues to digest key insights from the BEST-CLI randomized controlled trial (RCT), attendees of Plenary Session 3 at the Vascular...
VAM 2023: SVS descends on Capitol Hill
Nearly 50 SVS members took advantage of VAM’s location near Washington, D.C., visiting Capitol Hill Tuesday to discuss legislation related to vascular surgery with...
VAM 2023: Slew of special SVS section sessions set for Thursday
The SVS includes five special sections for different member groups, including physician assistants, women, young surgeons, surgeons in community practice and the Subsection on...
Crawford panel focuses minds on challenges facing vascular surgery workforce numbers
Yesterday's E. Stanley Crawford Critical Issues Forum, which looked at ways to address the pipeline of sources feeding the vascular surgery pool of talent,...
Sex-related disparities in lower-extremity revascularization outcomes brought into focus
Women are more likely to undergo reintervention after lower extremity revascularization for peripheral arterial disease (PAD) compared to male patients with similar limb salvage...
Endothelial cell granted superhero status in invited research presentation
“The endothelial cell is the superhero of the vascular system,” Kathryn L. Howe, MD, PhD, FRSCS, a vascular surgeon-scientist at the University of Toronto...
Significant life and limb gains for claudicants who stop smoking before lower-extremity bypass
Long-term overall survival (OS) and amputation-free survival (AFS) are outcomes that rebound in claudicants who quit smoking prior to elective surgery—and they mirror those...
VAM is ‘in the room where it happens’
To borrow from the hit musical “Hamilton,” VAM 2023 takes place right near Washington, D.C., the seat of power, and “the room where it...
Safety benefits mean TCAR may be preferable approach in radiation-induced carotid stenosis
A study set to be presented at VAM (14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery revascularization (TCAR)...
Base revascularization strategy on effectiveness in restoring adequate and durable limb perfusion, BEST-CLI subanalysis...
The results of a subanalysis of the BEST-CLI trial found that patients with chronic limb-threatening ischemia (CLTI) who were deemed suitable for open lower-extremity...
Global perspectives take center stage in second annual WFVS session at VAM
“The intellectual exchange of information and a better understanding of unique global perspectives has brought the leading societies closer,” Palma Shaw, MD, MBA, secretary...
Integrated vascular surgery program features may optimize trainee wellness and decrease attrition
Today’s program at the 2023 Vascular Annual Meeting (VAM) will feature the presentation of an abstract by R. Debbie Li, MD, Loyola University Medical...
VAM 2023: Learn at lunchtime
The Society for Vascular Surgery has added four lunchtime learning sessions to the VAM opening day.
Topics are both clinical and non-clinical, ranging from planning...
Study finds carotid stent fracture rate to be negligible but long-term research needed
Presenter Neeta Karani, MD, from Bronson Healthcare, Kalamazoo, Michigan, is set to elucidate findings that consider the incidence of carotid stent fractures and their...
‘First’ study to identify endothelial cell-cell communication via bidirectional secretion of extracellular vesicle cargo...
Award-winning vascular resident talks about the science behind her work, which her mentor says is “moving the needle on every front.”
University of Toronto surgeon-scientist...
VAM 2023: President-elect zeroes in on complexity of issues within vascular surgery pipeline
The Vascular Annual Meeting (VAM) E. Stanley Crawford Critical Issues Forum this year probes the problems and the challenges facing the vascular surgery workforce...
More research needed but lithotripsy plus TCAR ‘an answer’ in certain carotid disease patients
Earlier this year, researchers debuted single-center experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularization (TCAR) into patients with...
The essential ‘need’ for vascular surgeons in pulmonary embolism treatment paradigm
The specter of pulmonary embolism (PE) as a common and lethal disease process—with mortality of massive PE static at about 50% for decades while...
VQI@VAM: Quality takes center stage at VQI meeting, initiative making much out of zero
Over the past several months, the Society for Vascular Surgery’s Vascular Quality Initiative (VQI) hit some important milestones, including registering procedure number 1,000,000 in...
VQI@VAM: Social media helps promote safe technique, study finds
A social media campaign promoting educational videos proved efficient and cost-effective, and similar campaigns will be useful for quality improvement projects directed toward medical...
BEST-CLI vs. BASIL-2: Different questions yield different answers
Medical editor Malachi Sheahan III, MD, takes a look at seemingly conflicting results from the landmark BEST-CLI and BASIL-2 trials, and asks what they...
‘Nobody believed us’: Vascular giant discusses overcoming skeptics to make specialty-defining breakthroughs
Malachi Sheahan III, MD, Vascular Specialist’s medical editor, speaks to living legend and limb-salvage pioneer Frank J. Veith, MD, on the contents of his...
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients,...
VAM 2023 beckons
Our annual gathering is almost here. After months of planning, our premiere educational event in vascular surgery, the Vascular Annual Meeting (VAM), opens June...
FDA seeks to ‘modernize’ clinical trials with new draft guidance
The Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and...
‘Sonolysis is back’ after safely reducing endarterectomy stroke risk in randomized trial
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...
The top 10 most popular Vascular Specialist stories of May 2023
Last month, Vascular Specialist most piqued reader interest with a commentary from the editor-in-chief on why he supports the decision by the Southern Association for Vascular...
Vascular surgery moves to assess trainees’ competence with EPAs
For surgeons, “EPA” means not the “Environmental Protection Agency” but “Entrustable Professional Activity”—and they’re going to change surgery training. A pilot rollout for vascular...
SVS Foundation announces 2023 student fellowship awards
The Society for Vascular Surgery (SVS) Foundation has announced the winners of the 2023 Student Research Fellowship Awards.
The award is for undergraduate college and...
SVS webinar discusses BEST-CLI and early impacts on practice
A recording of the inaugural “SVS Presents” virtual educational session, on the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
Interim data find ‘no evidence of benefit’ for carotid revascularization additional to optimized medical...
Interim results from the ECST-2 randomized controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
Urban residents have smaller risk of mortality from chronic limb-threatening ischemia
A new study using data from millions of patients hospitalized across the U.S. has determined whether population density and associated urban versus suburban versus...
Advance: Navigating the policy and political processes on Capitol Hill
The underlying processes associated with advocacy—whether legislative, regulatory or political—are arduous and complex. As a result, measures of “success” are often characterized by progress...
We can honor the past without living in it
Malachi Sheahan III, MD, peels back the layers on why a decision by the Southern Association for Vascular Surgery (SAVS) to replace its signature...
Insights from largest chronic limb-threatening ischaemia study to inform quality of care improvements
Data from a cohort of one million patients with chronic limb-threatening ischaemia (CLTI) were recently presented as late-breaking clinical research at the Society for Cardiovascular...
JETi registry provides “remarkable results” for peripheral thrombectomy system
Presenting “remarkable results” from the JETi registry—a prospective, multicenter, observational study which collected real-world data on the safety, performance and clinical benefits of the...
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami) hosted a series of abstract presentations. Among them was one by...
Correct coding for IVUS during venous and arterial interventions
The use of intravascular ultrasound (IVUS) can provide helpful information for assessment of pre- and post-intervention vascular status and, thus, is an important part of...
Happiness, well-being and culture are key ingredients for seeking ‘eudaimonia’
Although researchers describe eudaimonia as the practice of virtues like courage, wisdom, good humor, moderation and kindness, some have translated the writings of Greek...
Medical therapy gains highlight need to reassess carotid surgery
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies, MD, from Imperial College London in London,...
Five-year results of the LEOPARD trial published in the Journal of Vascular Surgery
Endologix has announced the online publication of the final five-year results of the LEOPARD trial in the Journal of Vascular Surgery (JVS). The study's...
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium...
Corner Stitch: Navigating the technology landscape as a vascular trainee
I vividly recall sitting in the back of the conference room as a medical student and marvelling at the various approaches that could be...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into context within real-world...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
A vascular mission: Defying assumptions in the fight against amputation in disadvantaged areas
Lyssa Ochoa, MD, is used to the assumptions. One: ”What a nice program you have.” Another: “It must be so nice that you can...
New ‘biopsychosocial’ roadmap set out to address PAD treatment and mental health impacts
A recent proposal has called for “whole-person, multidisciplinary interventions” after an interrogation of the interplay between lower extremity peripheral arterial disease (PAD) and mental...
Reinterventions after physician-modified endovascular grafts ‘non-detrimental’ to long-term survival
For the treatment of juxtarenal aortic aneurysms, reinterventions after physician-modified endovascular grafts (PMEGs) are non-detrimental to long-term survival. This is one of the main...
Study finds no correlation between TEVAR timing and uncomplicated type B aortic dissection outcomes
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective...
Efforts to move towards routine patch closure or eversion endarterectomy among all carotid surgeons...
A nationwide cohort study of over 9,000 patients shows that the “controversial” practice of arteriotomy closure for carotid endarterectomy (CEA) is associated with an...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
CX 2023: Venous, we have a perception problem
Venous disease care has a problem with optics in the context of growth in the number of venous procedures and the spectre of inappropriate...
Study finds anatomic positioning and physical activity type can cause device fatigue in the...
A recent multicentre, prospective study has found that stent deformations are greater in the common iliac vein with higher levels of hip flexion, as...
Corner Stitch: Spotlight on VESS 2023
This month, Corner Stitch highlights one of the papers recently presented at the Vascular and Endovascular Surgery Society (VESS) 2023 winter meeting in Whistler,...
Letter to the editor: The virtue of a social media presence for surgeons in...
Dear editor,
I recently read an article in Vascular Specialist regarding the new age of the “vascular surgery influencer” that discussed how the world of...
FDA approves dissection and transection indication expansion for RelayPro stent graft system
Terumo Aortic announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent graft device for the treatment of...
The top 10 most popular Vascular Specialist stories of April 2023
In April 2023, Vascular Specialist readers were drawn to an interview dissecting the role robotics play, and can play in the future, in vascular...
Xeltis presents six-month first-in-human data on aXess graft
Xeltis has presented “highly-encouraging” six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society (VAS;...
Cook Medical treats first patient in first-in-human clinical trial for venous valve
Cook Medical recently announced that the first patient has been treated in a clinical study to evaluate a new venous valve designed for treating...
Help fund future of vascular health by serving on SVS Foundation Board of Directors
The Society for Vascular Surgery (SVS) Foundation seeks applicants to fill a pair of two-year terms on the Foundation Board of Directors. The term...
Government Grand Rounds: Educating through advocacy
Since the initial launch of the Cancer Moonshot in 2016, the cancer community has made tangible progress towards ambitious goals, including accelerating scientific discovery...
Navigating the red tape: A case for hybrid ORs in the VA
The United States military has access to the most cutting-edge equipment to perform its duties, so we should expect nothing less for its veterans....
Research on aortic size index as predictor of AAAs in men vs women highlights...
Seeking a better understanding of why women with ruptured abdominal aortic aneurysms (AAAs) have worse outcomes when compared with men, a new study champions...
Women’s Vascular Summit 2023: The ‘changing’ landscape of AAAs in women
Since conducting an initial U.S. population-based study of gendered abdominal aortic aneurysm (AAA) trends spanning 40 years, Indrani Sen, MBBS, an assistant professor of...
Vascular community split over ‘death’ of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider, MD, professor of vascular and endovascular surgery at University of California San Francisco in San Francisco,...
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should...
VAM 2023: Gala organizers seek auction donations
The “Great Gatsby Gala” Committee is turning its attention to gathering auction items to entice bidders in both the Live and Silent auctions.
The sky’s...
Showcasing a ‘rewarding field’: student-trainee program at VAM deals with full spectrum of vascular...
Besides being able to attend the scientific and educational sessions at the Vascular Annual Meeting (VAM), medical students and general surgery residents have an...
First implant of custom-made thoracoabdominal hybrid device in North America announced
Terumo Aortic announced the first North American implant of a custom-made hybrid device, Thoracoflo.
A press release noted that the device is used to treat...
A call to arms: Reuse of mature venous conduits urged
“Recycle that vein!”—that was the appeal from the authors of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs) from patients...
Surmodics announces successful first patient use of Sublime radial access microcatheter
Surmodics has announced that Ankur Lodha, MD, an interventional cardiologist at the Cardiovascular Institute of the South in Lafayette, Lousiana, and Pradeep Nair, director...
FDA approves IDE for pivotal study of high-intensity focused ultrasound platform
The Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application for the VEINRESET multicenter pivotal study that will evaluate Sonovein...
VAM educational sessions set to cover gamut of clinical and vascular practice matters
With sessions covering a wide swath of topics important to vascular surgeons, including many proposed by Society for Vascular Surgery (SVS) members themselves, participants...
May Vascular Research Initiatives Conference program takes shape
With an emphasis on cells—structural and immune—the program for the May 10 Vascular Research Initiatives Conference (VRIC) in Boston next month is taking shape.
VRIC...
Intentional mentorship and pushing beyond representation
Chicago medical student Maria Paz, BS, discusses intentional mentorship—and why she believes it matters.
When I started medical school, I never imagined that the most...
SVS member named 2023 Presidential Leadership Scholar
Society for Vascular Surgery (SVS) member Anahita Dua, MD, has been named a Presidential Leadership Scholar for 2023.
She is one of 60 scholars in...
SVS announces officer candidates for 2023 election
The 2023 Society for Vascular Surgery (SVS) Nominating Committee has announced the candidates for the 2023 officer election. They are:
For SVS vice president,...
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem for enduring success
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T....
Society of Black Vascular Surgeons builds bridges, connects international dots
A decade ago, if he were asked to name 10 Black vascular surgeons, says one African American vascular chief, he could have come up...
Robotic surgery: ‘We’ve missed the boat on this,’ says Houston vascular chief
An emerging program at Houston Methodist aims to help prod those practicing in the vascular surgical space deeper into the field of robotic surgery.
The...
SVS Vascular Quality Initiative passes milestone 1,000th-center mark
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry recently announced it has achieved another milestone, with more than 1,000 centers...
Initial case series indicates lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
Trainees: Cases sought for three VAM sessions
Vascular trainees and medical students are invited to submit their best cases for three sessions at the Society for Vascular Surgery (SVS) Vascular Annual...
SVS-ACS verification program: Key former SVS president predicts need for additional reviewers
Former SVS President Anton Sidawy, MD, hopes the launch of the Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) “Vascular Verification...
Creating an AI-based tool to help clinicians perform precision AAA analysis
For University of Calgary, Alberta, Canada, vascular surgeon Randy Moore, MD, the route to a world of precision care for individual abdominal aortic aneurysm...
Tackling health insecurity ‘from the top down and the bottom up’
The feeling of being “uncertain, anxious and vulnerable” defines a creeping health insecurity problem riddling parts of the U.S. patient population—demographics who are underserved...
Award-winning paper finds F/BEVAR ‘feasible and safe’ in patients with failed aortic repairs
Presenting award-winning new research, Andrea Vacirca, MD, a research fellow at The University of Texas Health Science Center in Houston (UTHealth Houston), revealed how,...
The top 10 most popular Vascular Specialist stories of March 2023
In March 2023, the Vascular Specialist stories grabbing readers' attention were a response to a February letter addressing vascular surgeons' use of social media; an...
Former SVS President William Abbott, 1997–98, dies at 86
William Martin Abbott, MD, former president of the Society for Vascular Surgery (SVS), died peacefully in his home Jan. 9 after a brief illness....
SCVS 2023: DAPT linked to better post-TCAR outcomes versus other drug regimens
Recent data presentations have revealed reduced risks of stroke and mortality among transcarotid artery revascularization (TCAR) patients who receive dual antiplatelet therapy (DAPT)—both preoperatively...
Computational model found to predict early aortic abdominal aneurysm rupture
In Physics of Fluids, by AIP Publishing, researchers from the Indian Institute of Technology (BHU) Varanasi and Indian Institute of Technology Kanpur made a...
SCVS 2023: DAPT shows higher survival rate in patients with low WIfI scores, study...
A retrospective cohort study presented at the 2023 Society for Clinical Vascular Surgery (SCVS) Annual Symposium in Miami (March 25–29) has found lower-extremity bypass...
Getting medical devices to market: The future might not be now, says regulatory expert
The development of medical devices in the vascular space faces increasing challenges amid moves afoot at the Food and Drug Administration (FDA), according to...
Results from PROMISE II pivotal trial published, reinforcing ‘ transformational value’ of deep vein...
Results from the PROMISE II pivotal trial investigating transcatheter arterialization of the deep veins using the LimFlow system in so-called no-option chronic limb-threatening ischemia...
DAPT linked to better post-TCAR outcomes versus other drug regimens
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid disease...
SCVS 2023: Endovascular-first or -only approach to all CLTI patients ‘is not evidence-based care’
Michael S. Conte, MD, one of the foremost experts in the field of peripheral arterial disease (PAD), took attendees of the 2023 annual meeting...
Short neck AAAs: ‘Choosing what is best for the patient’
Navigating cases of abdominal aortic aneurysm (AAA) with short neck anatomy poses a serious challenge to vascular surgeons, but the list of potential options...
Pay SVS dues to receive SVS benefits, including VAM discount
With registration for the 2023 Vascular Annual Meeting (VAM) right around the corner, those people who have not paid their SVS 2023 dues have...
First US patient enrolled in Gore Viafort vascular stent pivotal study
W L Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, randomized, multicenter, single-arm study with...
Getinge receives FDA premarket approval for the iCast covered stent system
Getinge‘s iCast covered stent system has received premarket approval from the Food and Drug Administration (FDA) for the treatment of patients with iliac arterial...
Act now to keep CME credits, SVS urges members
Society for Vascular Surgery (SVS) members should act now so they do not lose earned continuing medical education (CME) credits.
The American Board of Surgery...
Study highlights need for ‘continuous comparative assessments’ to guide endograft treatment decisions
A recent study comparing outcomes of endovascular aneurysm repair (EVAR) patients has reported no statistically significant differences in mortality or secondary rupture rates between...
STEVECO trial calls into question randomization in the venous stenting field
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomized controlled trial (RCT),...
‘Time matters’: New study finds novel EHR workflow improves timeliness in vascular care
A novel, order-initiated workflow facilitated by the electronic health record (EHR) has been shown to improve timeliness of care for vascular surgery patients, decreasing...
Analysis finds no difference in TCAR outcomes between academic, community hospitals
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularization (TCAR) between academic and...
SVS, ACS launch new quality verification program
The Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) have launched the “Vascular Verification Program (Vascular-VP)," an ACS Quality Program...
Bioprosthetic venous valve: ‘We want to know that this is really working’
A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical...
Letter to the editor: The vascular influencer
Dear editor,
Reading “Likes, dislikes and reposts: The new age of the vascular surgery influencer,” by Drs. Jean Bismuth (@jeanbismuth) and Jonathan Cardella (@yalevascular), they...
Viz.ai receives FDA 510(k) clearance for abdominal aortic aneurysm AI algorithm
Viz.ai recently announced it has received Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA)....
ABCs for the treatment of lower-extremity acute DVTs
Ashish Gupta, MD, outlines his ABCs for confronting and treating patients with acute deep vein thrombosis (DVT) of the lower extremity, and how he...
From the SVS president: Supporting one another
The Society for Vascular Surgery (SVS) has a vision that is unwavering. We desire quality vascular care for all patients by providing our members...
SCVS 2023: Four decades of AAAs in the US: Rare epidemiological study establishes women...
Abdominal aortic aneurysm (AAA) diagnosis and repair occurs among women almost 10 years later than in men—with similar age-adjusted mortality—the 2023 Society for Clinical...
Vesteck completes first-in-human use of several Suture-Tight devices
Vesteck scientific advisory board members along with key opinion leaders from around the world have successfully completed the first three in-human cases with the...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the Food and Drug Administration (FDA).
A...
SVS member elected to RUC committee
SVS member David Han, MD, has been re-elected to the American Medical Association (AMA) Relative Values Scale (RVS) Update Committee (RUC). Han’s two-year term...
Corner Stitch: What I wish I had known in vascular training
Welcome newly matched vascular surgery residents into the fold! I am just over six months into my first attending position after completing my residency...
Government Grand Rounds: Culture of engagement
Welcome back to Government Grand Rounds, where the Society for Vascular Surgery (SVS) Advocacy Council discusses how sustained advocacy engagement is important for all...
SVS launches web-based perioperative care guide
The Society for Vascular Surgery (SVS) has launched its “Management Guide on the Perioperative Care of Patients with Vascular Disease,” a multidisciplinary resource for...
Venous stenting: ‘We need to evaluate use, appropriateness and clinical indication’
An analysis of venous stent usage trends in the United States from 2014 through 2021 showed a “significant increase” in stents per day placed...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Algorithm predicts females have higher risk for kidney damage after aneurysm repair
When receiving treatment for abdominal aortic aneurysm (AAA), female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study...
VAM 2023: Early-bird registration opens
Meeting registration and hotel reservations opened March 15 for the Society for Vascular Surgery (SVS) 2023 Vascular Annual Meeting (VAM). This year’s premiere educational...
EU ministers approve changes to MDR transition timetable
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical...
New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus aspirin following lower...
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical trial show that low-dose rivaroxaban plus aspirin resulted in a 33%...
‘Voices of Vascular’ series celebrates Women’s History Month
The contributions of the Society for Vascular Surgery’s women members take center stage this month as part of the SVS Foundation’s “Voices of Vascular”...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...
Apply for Brandeis health policy program by March 15
Society for Vascular Surgery (SVS) members have until March 15 to apply for a scholarship to attend the Executive Leadership Program in Health Policy...
RESCUE trial shows reduction in segmental and main pulmonary artery occlusions
Robert A. Lookstein, MD, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital...
‘SVS Presents’ provides enhanced learning opportunities
The Society for Vascular Surgery (SVS) will debut “SVS Presents” April 12, a monthly webinar series that provides an evening of educational programming for...
AVF 2023: Results from first US trial of Sonovein delivered
The 2023 annual meeting of the American Venous Forum (AVF) heard the final results from the first U.S. trial of the emerging varicose vein...
The top 10 most popular Vascular Specialist stories of February 2023
In February 2023, the hits with Vascular Specialist readers included positive safety and efficacy findings from the PRESERVE trial; the announcement of the scientific program...
VESS 2023: pMAC score found to be ‘important predictor’ of CLTI revascularization outcomes
Having observed a strong relationship between calcification and subsequent limb loss, a research team led by investigators from the University of California San Francisco...
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in high-risk PE patients
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were...
AVF 2023: Investigators report update on three-year first-in-human results for bioprosthetic venous valve
Researchers in Colombia behind the first-in-human study of a novel bioprosthetic venous valve designed to treat chronic venous insufficiency (CVI) reported three-year results among...
AVF 2023: One-year analysis of CLOUT registry reveals ‘significant and sustained’ long-term clinical improvements
Interim one-year outcomes from the multicenter, prospective, single-arm CLOUT registry investigating use of the ClotTriever thrombectomy system in all-comer patients with deep vein thrombosis...
New study demonstrates IVC filters ‘safe and effective’ in treating venous thromboembolism
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
‘Urgent action needed’ to improve implementation of guideline-directed medical therapy for PVI
Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry between...
BioGenCell begins recruitment for clinical trial of stem cell-based treatment for preventing limb amputation
BioGenCell has announced that it is recruiting for an international clinical trial to assess the company's stem cell-based therapy for chronic limb-threatening ischemia patients...
SVS DEI Committee launches ‘Voices of Vascular’ series
To help celebrate the diversity in the vascular surgery specialty, the Society for Vascular Surgery Diversity, Equity and Inclusion Committee has launched “Voices of...
More than a research project: The vascular trainee’s role in tackling disparities in peripheral...
One of my earliest clinical experiences with vascular disease was as a high school student shadowing at a busy urban hospital in Detroit. A...
March’s free-access articles in JVS, JVS-VL
The March issues of the Journal of Vascular Surgery (JVS) and JVS: Venous and Lymphatic Disorders (JVS-VL) include eight articles that will be available...
VAM 2023 meeting set to take place as exclusively in-person event
A block party on opening day, session recordings available daily and—of course—the educational and scientific sessions for which the Society for Vascular Surgery’s Vascular...
Strategic planning session outlines SVS priorities for coming year
Key leaders from the society for Vascular Surgery (SVS) gathered in mid-January for a two-day Strategic Board of Directors (SBOD) meeting to work through...
Likes, dislikes and reposts: The new age of the vascular surgery influencer
The brave new world of social media, with its TikToks and Kardashians, has now invaded our once-sane specialty. No, this is not a veiled...
The case for aggressive intervention on symptomatic carotid web
The lead investigator behind new research from a center in Louisiana outlines how his new study—believed to be the largest single-institution analysis of symptomatic...
New Government Grand Rounds series highlights how perspective matters in advocacy
Matthew Sideman, MD, and Megan Marcinko, MPS, unveil new advocacy column aimed at drilling into the actions of Congress, and how they impact vascular...
Biotronik launches Oscar multifunctional peripheral catheter
Biotronik has announced the Food and Drug Administration (FDA) 510(k) clearance and CE mark of its Oscar (One Solution: Cross. Adjust. Restore) multifunctional peripheral...
SVS annual meeting introduces early-bird registration
The SVS is introducing a three-tiered pricing plan for the 2023 Vascular Annual Meeting (VAM). Early-bird rates start when registration opens March 15.
The cost...
Five-year outcomes of ESAR in patients with short neck
Cohort analysis shows no migrations, a low rate of ruptures, and positive sac regression, researchers say.
Five-year outcomes in patients with short neck abdominal aortic...
Educate, educate, and educate again: The continuing quest for appropriate venous care
Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of...
VRIC: ‘High value placed on supporting young researchers,’ 2022 trainee awardee says
Warm and inviting. Plenty of engagement at each presentation. A straightforward format that allows everyone to participate at all presentations. Sense of unity. Great...
The top 10 most popular Vascular Specialist stories of January 2023
In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate...
Patients with claudication receive more ‘aggressive’ surgical management in high-competition regions, study finds
Demonstrating the “susceptibility” of care delivery to regional market competition, M. Libby Weaver, MD, presented the case that intermittent claudication (IC) is a “novel...
New book penned by vascular icon charts career in surgery, revolutionary spirit
A new memoir penned by former Society for Vascular Surgery (SVS) President and vascular surgery leader Frank J. Veith, MD, which touches on...
Equivalency to clinical practice ‘varies considerably’ across recent carotid intervention trials
The transferability to real-world clinical practice of contemporary randomized controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably,” according to a recent analysis...
SVS: Pay 2023 dues to avoid lapse in benefits
Members, have any of you missed your most recent issue of Journal of Vascular Surgery (JVS)? If so, it could be because your 2023...
Abbott announces agreement to acquire Cardiovascular Systems
Abbott and Cardiovascular Systems (CSI) have announced a definitive agreement for Abbott to acquire CSI. Under terms of the agreement, CSI stockholders will receive...
Spotlight: SVS members take up new positions, make endowment
Sean Lyden, MD, is now chief medical consultant for VESTECK and has joined the VESTECK Scientific Advisory Board. VESTECK is an early-stage medical device...
SVS Foundation board approves latest pilot programs to help underserved
The SVS Foundation has awarded grants to two Society for Vascular Surgery (SVS) members to help them serve the underserved as part of the...
Coding: New CPT codes for percutaneous arteriovenous fistula creation
For the 2023 Current Procedural Terminology (CPT) code set, two new codes (36836 and 36837) have been added that describe percutaneous arteriovenous (AV) fistula...
Sex found to be ‘important variable’ in study and treatment of carotid atherosclerosis
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating...
Vascular surgery oral boards text seeks to fill certifying void
Think of it as the omega of the vascular surgical textbook literature, quips Andrew M. Wishy, DO. As a training resource, it fits neatly...
PRELUDE-BTK subanalysis highlights superior lumen gain, greater volumetric blood flow using serration angioplasty
Cagent Vascular has announced the results of a comparative subanalysis of the PRELUDE-below-the-knee (BTK) study versus plain balloon angioplasty.
The study was led by Marianne...
Sudanese vascular association readies for first-ever conference
The Sudanese Association of Vascular Surgeons (SudAVaS) has announced the scientific program behind its first-ever international conference, marking the occasion by celebrating the “first...
First patient enrolled in DEFIANCE trial of the ClotTriever system in DVT
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients...
SVS Foundation: Get ‘Gatsby’ Gala tickets today
Tickets—both individual and for tables—are selling faster than a Gin Rickey during Prohibition for the Society for Vascular Surgery (SVS) Foundation’s “Great Gatsby Gala,”...
VESAP5: Now up to 25% off
With the expiration of the fifth edition of the Vascular Education and Self-Assessment Program (VESAP5) in July, the Society for Vascular Surgery (SVS) is...
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons and better coverage...
Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory...
High-risk venous stasis ulceration patients show similar healing rates after multi-modal surgical therapy
A single-center evaluation of contemporary, multi-modal surgical therapy for venous stasis ulceration (C6 disease) suggests high-risk patients showed similar healing rates at one year,...
Has the risk in the value-based payment model been sold as another ‘shiny new...
Value-based payments (VBP), or “volume to value,” was the new buzz word over a decade ago, promising yet another chimera in ways to reimburse...
Back to basics: All the things I love about vascular surgery
Recently, after completing a difficult open aortic operation with my attending, a bright M3 asked me, “Why vascular surgery?” The question didn’t catch me...
‘Unique’ vascular meeting set to update surgeons, prioritize audience debate
Prioritizing “entertaining and informative” sessions, the 29th Annual Pennsylvania Hospital Vascular Symposium and the 3rd Annual Pennsylvania Hospital/University of Pennsylvania Non-invasive Vascular Laboratory Symposium...
Get FIT: Applications for VQI Fellowship in Training program open
The Fellowship in Training (FIT) from the Society for Vascular Surgery’s Vascular Quality Initiative (SVS VQI) introduces residents and fellows in vascular-focused programs to the...
The year in review: 2022 was an amazing 12 months for SVS
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023.
Executive Director...
SAVS reveals 2023–24 officeholders, including new president-elect
The Southern Association for Vascular Surgery (SAVS) officially announced its 2023–24 slate of officeholders following the conclusion of the recent SAVS annual business meeting.
The...
New SVS series zeroes in on government’s impact on vascular surgery
Starting next month, the Society for Vascular Surgery (SVS) will begin a series of articles focusing on how the actions of Congress and regulatory...
BEST-CLI: Analysis finds correlation between WIfI stage four CLTI and reports of poorer mental...
The BEST-CLI dataset has revealed a correlation between wounds, ischemia and foot infection (WIfI) stage and poorer quality of life due to mental, rather...
Surmodics provides regulatory update related to FDA premarket approval application for SurVeil
Surmodics recently announced it has received a letter from the Food and Drug Administration (FDA) related to its premarket approval (PMA) application for the...
Bentley launches rebranded crossing catheter
Germany-based endovascular device company Bentley announced the launch of the BeBack crossing catheter—formerly known as the GoBack—designed for the treatment of heavily calcified lesions...
Human-tissue engineered blood vessels remain durable at six years in PAD patients, latest study...
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72...
JVS group: Further changes in store for 2023
The planned changes for 2023 for the Journal of Vascular Surgery publications continue the momentum that began in mid- 2022. As former Editor-in-Chief Peter...
SVS unveils latest addition to JVS family of publications
The year 2023 promises to be one of change for the Journal of Vascular Surgery (JVS) family of publications, including the introduction of a...
SVS ends 2022 with latest ‘Week of Action’ to prevent Medicare payment reductions
The Society for Vascular Surgery (SVS) issued its thanks to December “Week of Action” participants.
Once again, SVS members showed incredible support for the Society’s...
SVS Foundation: ‘Gatsby’ Gala tickets on sale
Book your trip to the Roaring Twenties early, and save some money, perhaps for auction items. Early-bird ticket sales for the Society for Vascular Surgery...
SAVS 2023: President reveals upcoming change to Society seal
Southern Association for Vascular Surgery (SAVS) President William D. Jordan Jr., MD, used a portion of his 2023 Presidential Address to outline ways in...
SVS Foundation changes name of program aimed at providing care for underserved patients
The Society for Vascular Surgery (SVS) Foundation program formerly known as VISTA has a new name. VISTA—an acronym for Vascular Volunteers In Service To...
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society...
SAVS 2023: Study points toward CKD patients who would most benefit from renal artery...
A new study probing which chronic kidney disease (CKD) patients would benefit most from renal artery stenting points toward those who experience a more...
SAVS 2023: Planned and unplanned vascular assists found to improve outcomes
An award-winning paper presented at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, established an association between...
Membership clears bylaws changes
The Society for Vascular Surgery (SVS) voting membership voted to approve proposed changes to the bylaws that will change the composition of the Society’s...
Deadlines coming for scholarships, grants, awards
Deadlines arrive by March 1, with some as early as this month, for a number of Society for Vascular Surgery (SVS) and SVS Foundation...
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected pulmonary...
Medtronic announces first enrollment in head-to-head global randomized trial evaluating durability of EVAR
Medtronic has announced the first patient enrollment in the ADVANCE trial, a head-to-head randomized controlled trial of two leading aortic stent graft systems, the...
ESVS AAA guidelines alert recommends ‘enhanced surveillance’ in patients treated with Nellix device
In a newly released “focused update” to their 2019 recommendations, the European Society for Vascular Surgery (ESVS) abdominal aortic aneurysm (AAA) guidelines writing committee...
Deadline extension: VRIC 2023 abstracts now due Jan. 18
The Jan. 11 deadline to submit research abstracts on vascular disease and treatment for the 2023 Vascular Research Initiatives Conference (VRIC) has been extended...
SVS webinar on 3D printing showcases how technology could affect current and future practice
The recording of the Society for Surgery (SVS) webinar on three-dimensional (3D) printing in vascular surgery is now available on the SVS website.
The SVS...
Penumbra launches Lightning Flash mechanical thrombectomy system
Penumbra have announced the Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system.
“Lightning Flash features Penumbra’s novel Lightning intelligent...
Medicare payments: Congress fails to #StopTheFullCut
Despite intense pressure from the entire healthcare provider community, Congress failed to include provisions in its year-end legislative package to fully prevent Medicare payment...
Envision, private equity and patient care: Substituted values 2.0
He was only 41, already burdened with multiple health problems. Diabetes, hypertension and renal failure had put him on dialysis, caused the amputation of...
Summit dedicated to tackling key issues related to women’s vascular health and female workforce...
Linda Harris, MD, is a prolific attendee on the national and regional vascular meeting circuit, a noteworthy academic vascular surgeon with trainees and papers...
Vascular community starts process of wrestling with findings from BEST-CLI
One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BEST-CLI randomized controlled...
Learning culture, errors and Melinda French Gates
Workplace culture is fascinating to observe because it is nebulous and hard to measure. There is also often a perceived gap between the existing...
Varicose vein registry analysis finds women benefit from endovenous ablation with fewer complications
An evaluation of the Vascular Quality Initiative’s (VQI) Varicose Vein Registry (VVR) carried out by the Midwestern Vascular Surgical Society (MVSS) has found women...
Meta-analysis of PTS finds one in five at risk of long-term symptoms following isolated...
A meta-analysis is first to report the pooled risk of post-thrombotic syndrome (PTS) after isolated distal deep vein thrombosis (DVT). Researchers revealed a one-in-five...
Women’s Vascular Summit: Diving into issues around women’s vascular health and the female workforce
The Women’s Vascular Summit was established five years ago with the twin purposes of delving deeper into the issues that surround women’s vascular health...
SVS mourns passing of former president
Society for Vascular Surgery (SVS) members are mourning the death of James (Jimmy) S.T. Yao, MD, 88, former SVS president and Lifetime Achievement Award...
Students and residents: Attend VAM 2023 on a scholarship
Medical students and general surgery residents have the chance to change their lives. Perhaps they are still seeking some direction for their medical careers. Perhaps...
‘Impressive’ 12-month Flex vessel prep data presented at VEITHsymposium
VentureMed Group, a medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for peripheral arterial disease (PAD), announced...
VSGBI spotlights data-driven financial incentives for PAD revascularization
The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (Nov. 23–25) in Brighton, England, saw Rob Sayers,...
SVS issues membership dues reminder
To avoid a lapse in their benefits, Society for Vascular Surgery (SVS) members are encouraged to pay their 2023 member dues by Dec. 31.
These...
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis, VQI registry data...
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality...
Voting ends Dec. 18 on SVS bylaws revisions
Active and Senior Society for Vascular Surgery (SVS) members in good standing have until Dec. 18 to cast their ballots to change the composition...
Efemoral Medical closes financing round to fund ongoing study of its vascular scaffold system
Efemoral Medical has today announced the closing of its $4.9 million preferred Series A1 round. Supported by existing investors as well as an experienced...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device...
Endologix receives FDA approval of PMA supplement for AFX2 system
Endologix recently announced that it has received Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2 system.
According...
Corner Stitch: A reflection on 2022…
This month's column chronicles the exciting year we’ve had here at Corner Stitch. As the section editor, I’ve been most proud of the various...
The 10 most popular Vascular Specialist stories of November 2022
Among November's most read Vascular Specialist stories were updates from the BEST-CLI trial in the form of new data and funding; a guest...
WVS 2022: New evidence of radiation reduction benefit emerges
Surgical augmented intelligence in the form of 3D mapping during complex aortic procedures can decrease radiation exposure, fluoroscopy time and contrast use when combined...
EVS 2022: Weaving magic in academic vascular surgery at JVS
Past Journal of Vascular Surgery (JVS) group editor-in-chief Peter Gloviczki, MD, invoked his hobby of magic to help illustrate what it requires to take...
Veterans Affairs: A call to surveillance
For many of those injured in combat, the transition in care from the Military Health System (MHS) to the Veterans Health Administration (VHA) can...
MVSS 2022: Study finds no link between frailty score and surgical site infection
A vascular surgery-specific composite frailty score was not associated with with risk of surgical site infection in patients undergoing lower-extremity revascularization in a review...
EVS 2022: New study shows ‘encouraging increase in academic footprint of female-driven research’
How does vascular surgery compare to other specialties in the growth of gender diversity in published research? “Are we leaders in the field, or...
For SVS Foundation Gala, prepare to return to the Roaring 1920s
Attendees at the 2023 SVS Foundation Gala will be taking a trip 100 years back in time—to the Roaring Twenties and Prohibition.
The “Great Gatsby...
Conference watch: Submit research to VRIC, VAM
Submissions already are open for 2023 Vascular Research Initiatives Conference (VRIC), which will be May 10, 2023, in Boston. The conference includes abstract sessions,...
Vascular trainee-developed VSITE review book sees sales soar
A new review textbook developed by a vascular surgery resident with the aim of helping fellow trainees prepare for milestones like the Vascular Surgery...
SVS 10-year research goals: Why create research priorities?
As was the case with the 2011 set, researchers hope the updated priorities will serve as a starting point to align research efforts within...
SVS reveals research priorities for next decade
The Society for Vascular Surgery (SVS) Research Council has updated its top 10 research priorities, originally published in 2011, with patient-centered outcomes and personalized...
SVS vascular leaders: Cohort four of Leadership Development Program selected
Twenty-nine people have been selected for development as future leaders of the profession and the Society for Vascular Surgery (SVS).
They represent cohort four of...
NESVS 2022 Presidential Address: ‘We can create a bold new future for vascular surgery:...
“Collaborate, innovate, mentor, champion DEI and relish the opportunity to form deep connections with our amazing patients.” This was the key take-home message...
BEST-CLI: Optimal medical therapy adherence ‘well below’ recommended level at baseline
A significant proportion of patients enrolled in the BEST-CLI trial did not meet optimal medical therapy (OMT) guideline-based recommendations at the time of their...
Dec. 12 webinar to examine 3D printing for vascular imaging
Society for Vascular Surgery (SVS) members can learn some of the ins and outs of three-dimensional (3D) printing for vascular imaging at a webinar...
Roundtable on varicose veins guidelines set for Dec. 6
A virtual, multidisciplinary and interactive roundtable discussion on varicose veins will be held Dec. 6.
The free roundtable, set for 6 to 7:30 p.m. CST,...
Vascular surgeons: The ‘oncologists’ of the surgical arena
Like any good presentation I feel obligated to start with my disclosures: 1) I am married to a woman who decided to pursue a...
Swiss parliament votes to accept FDA-approved medical devices
The Swiss Federal Assembly has voted in favor of accepting medical devices with the Food and Drug Administration (FDA) marketing authorization in Switzerland.
A motion...
Diversifying clinical trials: ‘There needs to be some kind of cultural competency’
The COVID-19 pandemic exposed lingering mistrust in the U.S. healthcare system among patients from minority communities as physicians continue to confront the conundrum of...
Eastern Vascular gathering challenged to forge next generation of evolution
Evolution was the core theme of the Presidential Address Robert Rhee, MD, delivered from the Eastern Vascular Society (EVS) annual meeting stage in Philadelphia...
Bright future predicted for JVS internship program
This month on Corner Stitch, Christopher Audu, MD, profiles a new and innovative program offered by the Journal of Vascular Surgery (JVS). It’s called...
Miss the SVS webinars? Take advantage of the recordings
The Society for Vascular Surgery (SVS) hosts a number of Town Halls, roundtables and webinars for the benefit of its members.
In the past few...
Deadline extension: SAVS extends travel scholarship application cut-off for 2023 meeting
The Southern Association for Vascular Surgery (SAVS) has announced a deadline extension to Dec. 5 for 20 travel scholarships that are available to medical...
VAM 2023: Apply for international scholars program by Dec. 31
Young vascular surgeons from outside the United States and Canada have until Dec. 31 to apply for scholarships to attend the 2023 Vascular Annual...
Spotlight: SVS members in the news
Several SVS members have been making moves recently, attracting recognition in the form of awards and promotions.
Katherine Gallagher, MD, of the University of Michigan,...
Viz.ai announces positive new data from large aortic dissection AI real-world study
Viz.ai recently announced new data from a large aortic dissection artificial intelligence (AI) real-world study that supports the use of its AI technology for the detection...
First-in-human patients continue to benefit from VenoValve at average of three years post-surgery, new...
Positive long-term, three-year observational data from a cohort of patients that participated in the previously concluded VenoValve (Envveno Medical) first-in-human clinical trial were recently...
Complete SVS member priorities survey by Nov. 22
To help the Society for Vascular Surgery (SVS) chart a path into the future, members—and non-members alike—are asked to complete an ongoing survey by...
SWING trial 12-month data: Novel sirolimus DCB shows ‘great promise’ in ‘challenging’ CLTI population
The Sundance (Surmodics) sirolimus drug-coated balloon (DCB) has an “excellent” safety profile in a “challenging, real-world, predominantly CLTI population,” and has a primary...
VEITHsymposium panel probes ‘value’ of artificial intelligence in vascular surgery
A session at the 2022 VEITHsymposium in New York City (Nov. 15–19) focused on new concepts, machine learning, and artificial intelligence (AI) in vascular...
The top 10 most popular Vascular Specialist stories of October 2022
The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS)...
Veterans Day: Remembering Korea, ‘accidental pioneers’ and M*A*S*H
During November—Nov. 11, specifically—the United States salutes and honors all those who have served this country in its armed forces. This November, the Society...
New diversity, equity and inclusion pillar signals additional priority for SVS Foundation
The Society for Vascular Surgery (SVS) Foundation has been guided by the three long-term pillars of research and innovation, community vascular care and patient...
Chocolate Touch DCB for treatment of peripheral arterial disease receives FDA approval
Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter...
NESVS Robert R. Linton Lecture features complex aortic masterclass from Europe
World-leading aortic surgeon Stéphan Haulon, MD, from the Aortic Centre at Hôpital Marie Lannelongue in Paris, France, took attendees of the 2022 New England...
SOOVC sub-section introduces two awards
The Society for Vascular Surgery's sub-section for those who provide service in outpatient settings has created two professional development opportunities for its members, a...
CMS: An update on quality measures for vascular surgery
An upcoming national reporting change/addition from the Centers for Medicare and Medicaid Services (CMS) includes three important elements of which Society for Vascular Surgery...
SVS adds ‘service’ criterion to Distinguished Fellows process
The Society for Vascular Surgery (SVS) has added service to the Society as an important component of its Distinguished Fellows process, an honor annually...
First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients...
The first results from the BEST-CLI randomized controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...
SVS asking members to expand diversity in Nominating Committee
The Society for Vascular Surgery (SVS) will ask voting-eligible members to consider three revisions to article X of the SVS bylaws that would take...
Amplifi vein dilation system continues to show promise following latest first-in-human study update
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy, MD, from Washington University School of...
Virtual visits versus in-person: Telemedicine study detects ‘substantial’ cost savings for patients
Virtual consultations appear comparable to care received in-person when it comes to clinical outcomes as well as patient and practitioner satisfaction, a systematic review...
‘Significant’ increase in atherectomy use in US largely driven by office-based procedures, VQI data...
In the United States, atherectomy use in peripheral vascular interventions (PVIs) “more than doubled” from 2010 to 2019, with office-based procedures a “major driver”...
Disrupt PAD III observational study results confirm safety and effectiveness of IVL in complex...
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and...
End-stage CLTI: Deep-vein arterialization procedure demonstrates amputation-free survival rate of 66% at six months
Six-month results from the PROMISE II trial of the LimFlow deep-vein arterialization system showed an overall amputation-free survival of 66%—“well above” the primary endpoint...
BEST-CLI attracts $3.3m funding injection to continue data analysis
The Novo Nordisk Foundation has made a $3.3 million contribution toward the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
CEA, TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularization, with CEA and transcarotid...
SurVeil DCB demonstrates sustained durability of safety, efficacy endpoints in TRANSCEND
In the TRANSCEND clinical trial, the SurVeil drug-coated balloon (DCB; Surmodics) demonstrated "excellent efficacy and safety" out to 24-month follow-up. This is according to...
New analysis: Four multicenter trials support primary use of drug-coated balloons over bare metal...
A patient-level, propensity-adjusted comparison of three-year results from a quartet of prospective, multicenter trials support the primary use of drug-coated balloons (DCBs) versus bare...
‘Excellent’ three-year results presented for the BioMimics 3D stent in longer lesions
At the 2022 Vascular Interventional Advances (VIVA) meeting (Oct. 31–3 Nov. 3), Michael Lichtenberg, MD, from Arnsberg Clinic, Arnsberg, Germany, reported a subgroup analysis...
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence base
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results...
Abre stent data show ‘struggle to maintain patency’ among post-thrombotic syndrome patients
The Abre venous stent demonstrated three-year primary patency rates of 97.1%, 76.5% and 70.4% respectively for non-thrombotic iliac vein lesion (NIVL), acute deep vein...
An open letter to the National Rifle Association
Hello,
I think it is time we talked about guns. I know you don’t like to discuss these things after a school shooting, so I...
A recent snapshot of pediatric vascular trauma injuries
A study of major pediatric vascular injuries delivered in the Vascular and Endovascular Surgery Society (VESS) Paper Session during the 2022 Vascular Annual Meeting...
Study: Combined antiplatelet, NOAC use linked to worse limb outcomes after suprainguinal bypass
A new analysis that found combined antiplatelet and novel oral anticoagulant (NOAC) therapy after suprainguinal bypass was associated with worse limb outcomes and equivalent...
Gore completes first-in-human implants of Viafort vascular stent
W. L. Gore today announced the first implants of its investigational Gore Viafort vascular stent as part of a recently initiated pivotal clinical study for...
The top 10 most popular Vascular Specialist stories of September 2022
September's top stories featured news of a trial to evaluate women's experience of early endovascular aneurysm repair, and of a special women-focused edition...
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular disparities award
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to...
‘Week of Action’ raises awareness of SVS advocacy activities
From sending emails to lawmakers, posting on social media to amplify legislative issues, and donating to the Society for Vascular Surgery Political Action Committee...
Regional vascular presidents measure state of specialty
Vincent Rowe, MD, and Raghu Motaganahalli, MD, delivered Presidential Addresses at the Western Vascular Society (WVS) and the Midwestern Vascular Surgical Society (MVSS) that...
Slew of regional vascular societies welcome new leaders for 2022–23
A number of regional vascular societies across the U.S. and Canada introduced their 2022–23 slew of officers during their annual meetings across the fall...
CX Aortic Vienna: Onus on industry to meet clinician desire for devices that function,...
The need for vascular companies to home in on developing longer-lasting devices—perhaps even ones that adapt over time to match patients’ changing anatomies—was underscored...
Vascular practice: Financial wellness is focus of Nov. 2 SVS webinar
Responding to members’ requests for more information on financial education, a nationally known estate and tax attorney will provide information and guidance on financial...
SVS weighs in on 2023 Medicare payment rules for physicians and hospital outpatient services
The Society for Vascular Surgery (SVS) has submitted comment letters in response to the proposed rules issued by the Centers for Medicare and Medicaid...
NESVS 2022: Study illustrates relationship between increased distance from medical center and higher treatment...
Research detailing that patients traveling farther for complex aortic surgery have higher procedural costs, postoperative imaging costs, and comprehensive one-year costs was among the...
Signal-to-noise ratio: Thoughts on fine-tuning feedback during vascular surgery training
I recently took the Registered Physician in Vascular Interpretation (RPVI) exam. While studying for it, one of the concepts that stood out was the...
Prepare to submit research for VAM, VRIC 2023
The Society for Vascular Surgery (SVS) wants members’ research on vascular disease for the 2023 Vascular Research Initiatives Conference (VRIC) and the 2023 Vascular...
SVS prepares for important member survey to be held in November
The Society for Vascular Surgery (SVS) will survey members in November to continue to track demographic changes, how members would like the SVS to...
SVS officer elections 2022: A glimpse into the electorate
The SVS Executive Board highlights details of the most recent Society for Vascular Surgery (SVS) elections to inform members and further strengthen the process.
In...
Only a few seats remain for CPVI hands-on skills course
Only a few spots remain available for the Society for Vascular Surgery’s new Complex Peripheral Vascular Intervention (CPVI) Skills Course. Today—Thursday, Oct. 20—is the...
EVS 2022: Study suggests lower rates of aortic rupture, mortality after TEVAR for uncomplicated...
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the...
Mortality drops for acute type A aortic dissection, still high for patients not receiving...
The chance of a patient surviving after an acute type A aortic dissection has improved significantly, but mortality remains high if not recognized early and repaired...
ABRE clinical study 36-month data show ‘long-term durability’ of venous stent system
Medtronic has announced the 36-month final results from the ABRE clinical study. The purpose of the ABRE clinical study was to evaluate the safety and...
Six-month data from SWING below-the-knee, first-in-human trial presented at AMP Europe
Six-month data from the Surmodics SWING first-in-human (FIH) study of the company’s Sundance sirolimus drug-coated balloon (DCB) were shared at the 2022 Amputation Prevention Symposium (AMP) held Oct....
Interacting with EMR best practice advisory ‘significantly’ improves AAA screening rates
Positively interacting with best practice advisory notifications is correlated with an increased rate of abdominal aortic aneurysm (AAA) screening, according to an analysis of...
Vascular surgeons step up for PAD awareness campaign in September
Walking is instrumental to keeping the 60,000 miles of blood vessels in the human body healthy—especially for patients with peripheral arterial disease (PAD). That...
Roundtable for treating CLTI: GLASS will make it clear
The final of three roundtables on treating Chronic Limb-threatening Ischemia (CLTI) will cover the Global Limb Anatomic Staging System—GLASS.
The virtual roundtable, on GLASS staging...
Terumo Aortic announces new technology add-on payment for Thoraflex Hybrid device in US
The Centers for Medicare and Medicaid Services (CMS) has granted approval of a new technology add-on payment (NTAP) for Terumo Aortic’s Thoraflex Hybrid device—used...
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in full US cohort
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients.
This is according to Catalin...
New study indicates cost-effectiveness of Denali IVC filter over Option device
Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter than with the Option IVC...
VEITHsymposium to include world federation session
The World Federation of Vascular Societies (WFVS) is set to hold a session in November during the VEITHsymposium in New York City. The 90-minute session...
Trainees step up to learn coding, reimbursement
The Society for Vascular Surgery’s (SVS) efforts in coding and reimbursement work have taken another step forward, with four new doctors now in training...
Ukrainian surgeons present clinical update on Human Acellular Vessel in vascular trauma at ESVS...
Humacyte recently announced the presentation of a clinical update on the Human Acellular Vessel (HAV) for the treatment of vascular trauma. The update was...
SVS launches program to ‘REACH 535’ lawmakers
To leverage the power of direct engagement with lawmakers on the part of constituents, the SVS advocacy team is launching a grassroots advocacy plan...
ESVS publishes ‘pioneering’ clinical practice guidelines on radiation safety
The European Society for Vascular Surgery (ESVS) has released clinical practice guidelines on radiation safety, which the writing committee notes are the first guidelines...
No time like the present: The moral imperative for advocacy in vascular surgery
“I’m so sorry but we have to cancel your surgery”—10 words any warm-blooded surgeon dreads uttering. This time around, it was not for the...
Corner Stitch: Audible Bleeding cuts down to vascular core
Many Corner Stitch readers subscribe to Audible Bleeding, the vascular surgery podcast for updates on all things vascular—from vascular knowledge, to reviewing key Journal...
SVS advocacy in action: Protecting and advancing the interests of vascular surgery
Deep in to the second half of the year, there is no rest for the weary regarding Society for Vascular Surgery (SVS) advocacy initiatives....
Experts establish international standard set of outcome measures for patients with VTE
The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...
WVS 2022: Study probes who benefits from EVAR among patients with chronic kidney disease
Patients with advanced chronic kidney disease (CKD) represent a high-risk group who may not benefit from elective endovascular aneurysm repair (EVAR) for abdominal aortic...
Annals of Vascular Surgery announces special issue dedicated to original work by women
The Annals of Vascular Surgery peer-review journal has announced an upcoming special issue dedicated to original work by women that is set to be...
Society for Vascular Surgery Vascular Quality Initiative celebrates one million procedures
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry announced this week it has now collected more than one million procedures...
Aortobifemoral grafting in the endovascular era: An exploration of the open procedure and its...
Aortobifemoral grafting for aortoiliac occlusive disease (AIOD) probably remains “very safe” in the era of endovascular repair, according to the senior author behind a...
WARRIORS randomized trial aims to examine early EVAR in women
This month a multinational collaboration of researchers received endorsement from the Global Cardiovascular Research Funders Forum (GCRFF) Multinational Clinical Trials Initiative for the WARRIORS...
Treating PAD: ‘Run, don’t walk, to sign up for this incredible course’
No matter if you’re a surgeon with a few years—or a few decades—of experience, faculty members of a new, upcoming Society for Vascular Surgery...
PAD: Endovascular revascularization ‘superior or not significantly different’ in terms of outcomes versus open...
A real-world analysis of peripheral arterial disease (PAD) patients in Canada indicated open revascularization may not offer a long-term benefit over endovascular intervention. In...
Black patients wait more than twice as long as White patients for rAAA repair,...
Black patients saw significantly delayed care for ruptured abdominal aortic aneurysms (rAAAs), with a Vascular Quality Initiative (VQI) analysis showing a median time from hospital...
TCAR: First patient enrolled in ROADSTER 3 post-approval study
Silk Road Medical has announced enrollment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicenter, single-arm...
The top 10 most popular Vascular Specialist stories of August 2022
The top 10 most-read stories on the Vascular Specialist website in August included a look at the state of diversity, equity and inclusion (DEI)...
Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose, according to late...